Status:

UNKNOWN

Gestational Diabetes Mellitus (GDM) in Pregnant Women

Lead Sponsor:

Long Island University

Collaborating Sponsors:

BROOKLYN INNOSEQ INC.

Conditions:

Gestational Diabetes Mellitus

Pregnancy Complications

Eligibility:

FEMALE

18-45 years

Brief Summary

The purpose of the trial is to discover and predict the development of GDM of pregnant women in their first trimester.

Detailed Description

Gestational Diabetes Mellitus (GDM) is a type of diabetes that affects pregnant women and often develops in the middle and later stages of pregnancy. GDM can lead to adverse maternal outcomes such as ...

Eligibility Criteria

Inclusion

  • Women between the age of 18-45 Groups A and B have to be confirmed pregnant by blood test (confirmed by medical records) Subgroups A1 and B1 are pregnant women in their first trimester Subgroups A2 and B2 are pregnant women in their second trimester Subgroups A3 and B3 are pregnant women in their third trimester

Exclusion

  • History of smoking or drinking during the pregnancy History of chronic diseases (cardiac, kidney, diabetes, hypertension, IBD,etc). Laxative use within 2 days prior to sample collection (The participant will be informed of the collection procedure by the recruiter and will be made aware of this requirement, we will also confirm when the first sample is taken through a phone call if for any reason the participant still made a mistake, will ask her to collect another sample to replace it) Development of any serious pregnancy complication during the participation period (e.g preeclampsia, preterm birth, miscarriage, etc) Excessive vomiting, diarrhea, or gastrointestinal symptoms for more than 5 consecutive days during the participation period. This will be confirmed through a weekly check-up call by the on-site recruiter or by Dr.Yin if the patient seeks treatment

Key Trial Info

Start Date :

November 9 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2024

Estimated Enrollment :

65 Patients enrolled

Trial Details

Trial ID

NCT05265741

Start Date

November 9 2021

End Date

December 31 2024

Last Update

April 13 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Long Island University

New York, New York, United States, 11201